OGN Executive Compensation
* In USD (Original Currency)|
Filing Date (SEC Report) |
Year | Reporting Name | Salary | Bonus | Stock Award | Incentive Plan Compensation | Other Compensation | Total |
|---|---|---|---|---|---|---|---|---|
| 2024-04-25 | 2021 | Sandra Milligan, M.D. Former EVP and Head of Research and Development | 670,357 | 0 | 1,622,634 | 492,083 | 43,149 | 4,932,735 |
| 2024-04-25 | 2023 | Kevin Ali Chief Executive Officer | 1,244,231 | 0 | 8,260,650 | 1,837,500 | 740,523 | 14,832,272 |
| 2024-04-25 | 2022 | Kevin Ali Chief Executive Officer | 1,203,769 | 0 | 7,345,176 | 1,837,500 | 896,544 | 13,532,980 |
| 2024-04-25 | 2021 | Kevin Ali Chief Executive Officer | 1,134,451 | 0 | 7,746,837 | 1,487,063 | 518,756 | 18,550,737 |
| 2024-04-25 | 2023 | Matthew Walsh EVP and Chief Financial Officer | 890,077 | 0 | 2,553,291 | 705,600 | 214,100 | 5,212,866 |
| 2024-04-25 | 2022 | Matthew Walsh EVP and Chief Financial Officer | 849,385 | 0 | 2,652,410 | 822,720 | 169,570 | 5,306,585 |
| 2024-04-25 | 2021 | Matthew Walsh EVP and Chief Financial Officer | 825,055 | 0 | 2,808,152 | 692,160 | 53,338 | 6,757,065 |
| 2024-04-25 | 2023 | Susanne Fiedler EVP and Chief Commercial Officer | 726,696 | 0 | 1,652,125 | 576,180 | 72,259 | 3,836,401 |
| 2024-04-25 | 2022 | Susanne Fiedler EVP and Chief Commercial Officer | 686,275 | 0 | 1,632,250 | 664,535 | 92,900 | 3,656,038 |
| 2024-04-25 | 2021 | Susanne Fiedler EVP and Chief Commercial Officer | 672,948 | 0 | 1,621,092 | 569,423 | 265,716 | 5,316,274 |
| 2024-04-25 | 2023 | Joseph Morrissey EVP and Head of Manufacturing and Supply | 740,769 | 0 | 1,652,125 | 588,000 | 206,244 | 3,737,009 |
| 2024-04-25 | 2022 | Joseph Morrissey EVP and Head of Manufacturing and Supply | 688,769 | 0 | 1,346,603 | 681,600 | 165,735 | 3,295,199 |
| 2024-04-25 | 2023 | Kirke Weaver | 650,000 | 210,656 | 1,314,174 | 445,900 | 134,569 | 3,192,693 |
| 2024-04-25 | 2023 | Sandra Milligan, M.D. Former EVP and Head of Research and Development | 788,462 | 0 | 2,065,157 | 627,200 | 188,558 | 4,356,713 |
| 2024-04-25 | 2022 | Sandra Milligan, M.D. Former EVP and Head of Research and Development | 731,423 | 0 | 2,040,286 | 720,000 | 152,938 | 4,269,640 |
| 2023-04-27 | 2021 | Susanne Fiedler EVP and Chief Commercial Officer | 672,948 | 0 | 1,611,914 | 569,423 | 265,716 | 4,556,589 |
| 2023-04-27 | 2022 | Sandra Milligan, M.D. EVP and Head of Research and Development | 731,423 | 0 | 2,426,072 | 720,000 | 152,938 | 4,655,426 |
| 2023-04-27 | 2021 | Sandra Milligan, M.D. EVP and Head of Research and Development | 670,357 | 0 | 1,611,914 | 492,083 | 43,149 | 4,075,364 |
| 2023-04-27 | 2022 | Joseph Morrissey | 688,769 | 0 | 1,601,223 | 681,600 | 165,735 | 3,549,819 |
| 2023-04-27 | 2022 | Kevin Ali Chief Executive Officer | 1,203,769 | 0 | 8,734,018 | 1,837,500 | 922,671 | 14,947,950 |
| 2023-04-27 | 2021 | Kevin Ali Chief Executive Officer | 1,134,451 | 0 | 7,731,558 | 1,487,063 | 518,756 | 16,851,265 |
| 2023-04-27 | 2022 | Matthew Walsh EVP and Chief Financial Officer | 849,385 | 0 | 3,153,939 | 822,720 | 169,570 | 5,808,114 |
| 2023-04-27 | 2021 | Matthew Walsh EVP and Chief Financial Officer | 825,055 | 0 | 2,808,152 | 692,160 | 53,338 | 6,558,489 |
| 2023-04-27 | 2022 | Susanne Fiedler EVP and Chief Commercial Officer | 686,275 | 0 | 1,940,880 | 664,535 | 92,900 | 3,964,668 |
| 2022-04-28 | 2021 | Kevin Ali Chief Executive Officer | 1,134,451 | 0 | 7,731,558 | 1,487,063 | 455,114 | 16,787,623 |
| 2022-04-28 | 2021 | Susanne Fiedler EVP and Chief Commercial Officer | 672,948 | 0 | 1,611,914 | 569,423 | 265,716 | 4,536,485 |
| 2022-04-28 | 2021 | Sandra Milligan, M.D. EVP and Head of Research & Development | 670,357 | 0 | 1,611,914 | 492,083 | 43,149 | 4,075,364 |
| 2022-04-28 | 2021 | Deborah H. Telman EVP and General Counsel and Corporate Secretary | 670,357 | 0 | 1,473,355 | 492,083 | 331,267 | 4,112,953 |
| 2022-04-28 | 2021 | Matthew Walsh EVP and Chief Financial Officer | 825,055 | 0 | 2,808,152 | 692,160 | 53,338 | 6,558,489 |
Disclaimer: The data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by our third party API www.financialmodellingprep.com, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore, Discounting Cash Flows Inc. doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Discounting Cash Flows Inc. or anyone involved with Discounting Cash Flows Inc. will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
